Browsing Tag
Generalized Anxiety Disorder
3 posts
Can Mind Medicine’s $242.8m war chest carry MM120 through three Phase III wins in 2026?
Mind Medicine strengthens its balance sheet with $242.8M funding and eyes three pivotal Phase III data readouts for MM120 in 2026. See why this matters.
Can Incannex Healthcare’s dual breakthrough in OSA and anxiety therapy lift IXHL shares in 2025?
Discover how Incannex Healthcare is converting major trial wins and smart capital moves into a stronger 2025 growth plan!
MindMed completes Phase 2b trial enrollment for MM-120 in GAD treatment
MindMed Inc., a clinical-stage biopharmaceutical company, has announced the completion of enrollment and dosing in its Phase 2b…